Clinical Trials Browser

Phase 2 × Unresectable Gallbladder Cancer × Clear all

NCT06423170 2024-05-21

A Single-arm Phase II Clinical Study of the Efficacy and Safety of Camrelizumab Combined With GEMOX for Unresectable GBCs

Phase 2 Recruiting

GastrointestinalGenitourinary

Unresectable Gallbladder Cancer

NCT05919095 2023-06-26

A Clinical Study of a Preoperative Translational Therapy for Unresectable Gallbladder Cancer

Phase 2 Not yet recruiting

GastrointestinalGenitourinary

Unresectable Gallbladder Cancer